Partner Sites
Executive War College
The Dark Report
Dark Daily
G2 Intelligence
Trends
Events
Digital Forums
Webinars
Resources
Ebooks
Infographics
White Papers
Magazine
Login
Subscribe Today
Business & Policy
Advocacy & Professional Affairs
FDA, CMS & Regulatory Frameworks
IVD Market
M&A, Consolidation & Competitive Landscape
Market Trends & Business Intelligence
Payer Policy
Public Health & Population Testing Strategy
Lab Operations
Budgeting, Cost Control & Purchasing Strategy
Procurement & Vendor Alignment
Remote/Hub-and-Spoke Testing Networks
Revenue Cycle Management
Sustainability & Resource Efficiency
Workflow Optimization & Lean Lab Design
Workforce, Staffing & Training
Compliance
Biosafety, Biosecurity & Risk Management
CLIA, Regulatory, & Accreditation
Data Integrity & Traceability
Proficiency Testing & External QC
Quality Control & Quality Assurance
Validation, Verification & Method Comparison
Emerging Tech
Cell & Gene Therapy Diagnostic Interfaces
Digital Pathology, AI & Computational Diagnostics
Genomics, Proteomics, & Metabolomics
Liquid Biopsy & Early Detection
Precision Medicine & Companion Diagnostics
Tools & Techniques
Analyzers, Automation, & Diagnostic Platforms
Consumables & Lab Supplies
LIMS, Data Systems & Digital Workflows
Liquid Handling & Laboratory Robotics
Microscopy & Digital Pathology Imaging
PCR & qPCR Systems
Sample Prep & Processing Systems
Sequencing & Multiomics Platforms
Diagnostics & Testing
Clinical Chemistry
Hematology, Hemostasis, & Urinalysis
Microbiology & Infectious Disease
Molecular Diagnostics
Pathology & Histology
Point-of-Care Testing
Specimen Collection, Transport, & Pre-Analytical Processes
Toxicology & Pharmacology
Subscribe
Subscribe Today
Home
/
Trends
/
Neuroscience Testing and Research
7-Part Series
Neuroscience Testing and Research
Exploring genetics, biomarkers, and research on neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS, focusing on early testing and detection, and therapeutic advances.
Read Series
Published
Articles in this Series
|
4 min read
Counting Down to Alzheimer’s Disease
by
Zahraa Chorghay, PhD
|
5 min read
Global Neurodegeneration Proteomics Atlas Reveals Key Disease Signatures
by
Zahraa Chorghay, PhD
|
3 min read
Capturing the Elusive: Why Multi-Protein Biomarkers Tests Are the Future of Measuring MS Progression
by
Ferhan Qureshi
|
3 min read
The Future of Biomarkers in Multiple Sclerosis Care
by
Stephanie Buxhoeveden, PhD, MSN, FNP-BC, MSCN
Updated
|
3 min read
New Biomarkers for Better Neurodegenerative Disease Diagnostics and Treatments
by
Russ Lebovitz, MD, PhD
|
4 min read
Discovering Novel Biomarkers for Rare Neurological Diseases
by
Jordan Willis, BSc
|
3 min read
Multiple Sclerosis as a Case of Mistaken Identity
by
Zahraa Chorghay, PhD
Read Series